Skip to main content

AI agents automate routine tasks across sales, support, and operations.

Desktop Screenshot
Loading signal evidence

Product memo

For who
B2B teams needing AI automation for routine tasks
Solves what
Automates routine business tasks across sales, support, and ops using AI agents.
  • AI agents handle routine work
  • Integrates with existing tools
  • Proactive task execution

Market demand

StartClaw keyword demand

4 keywords

Upgrade to Starter

Market demand is Starter-tier market intelligence.

SimilarWeb keyword snapshot · directional estimate.

In their own words

AI employees that run your business.

Connect your stack once, then let a reliable operator clear routine work across sales, support, and ops before your team logs in.

Deploy your OpenClaw AI agents instantly. Connect to WhatsApp, Telegram, and more. No servers to manage. Just your AI, running 24/7.

CTA: Hire now

Operator & company

Operators

1 person

Idan Mann

Founder · Profile verified

X @mann_idan

Company

Founded

Jan 2026

HQ

United States

Operating model

Business model

Saas

Platform

Web app

Audience

General

Payments

Stripe

Product channels

Builder strategy

ProvenRadar analysis

Strategy Type
Niche Specialist
Stage
Vc Growth
Effort
Small Team
About StartClaw Expand

AI agents automate routine tasks across sales, support, and operations.

Competitive context

5 peers · Same primary niche · Radar benchmark · StartClaw #2145.

OpenHive

OpenHive

#ai

open-hive.com

#2317

Radar rank

Tulsk

Tulsk

#ai

tulsk.io

#3024

Radar rank

JoAi

JoAi

#ai

joai.ai

#3219

Radar rank

Unlock full depth

Show the first useful rows, then lock deeper rows and full breakdowns.

Commercial cues

Model
subscription
Free tier
Yes
Trial
3 days

Pricing strategy

  • A 3-day free trial lets teams test agent capabilities risk-free.
  • Custom handles custom requirements.

Tech stack

Radix UIIntercomRailway

Source evidence

Current source facts supporting this analysis. They remain attributed and may be newer than the latest dossier refresh.

Evidence sources